Softwr

Healthcare · head to head

Fullscript vs Techcyte

Fullscript logo

Fullscript

Healthcare

Supplement dispensing for practitioners, free to use because it earns on the products

From
Free
Rated
-
Techcyte logo

Techcyte

Healthcare

AI digital pathology across clinical, veterinary and environmental laboratory disciplines

From
On request
Rated
-

The short version

  • Only Fullscript has a free tier, so it costs nothing to try first.
  • Each has a real cost: Fullscript the practitioner sets their own margin on products they clinically recommend, which is a conflict of interest that some professional bodies and patients view badly, and the platform makes the arrangement easy rather than making it visible.; Techcyte regulatory status runs the opposite way to what most buyers assume: the products are CE marked and clinically deployed in Europe while several United States offerings including Fusion Parasitology are labelled research use only and not for diagnostic use, so an American laboratory must verify each module individually.
  • They diverge on capability: Fullscript covers Protocol dispensing, Techcyte covers Fusion Parasitology Suite.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Fullscript and Techcyte actually diverge.

Attributes where Fullscript and Techcyte differ
AttributeFullscriptTechcyte
Starting priceFreeOn request
Pricing modelPer user per monthquote
Free tierYesNo
PlatformsWeb, iOS, AndroidWeb

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Fullscript

  • Protocol dispensing
  • Profit dispensary
  • Auto refill
  • Lab ordering
  • Patient app
  • EHR integration
  • Enterprise catalogue control

Only in Techcyte

  • Fusion Parasitology Suite
  • Cervical cytology
  • Haematology
  • Urinalysis
  • Bacteriology and mycology
  • Vetcyte
  • Scanner agnostic ingestion
  • Remote review

What people use each for

The jobs each tool is most often brought in to do.

Fullscript

  • A functional medicine practice that wants to stop holding supplement stock, cash and expiry risk in the clinicnot Techcyte
  • A dietitian or naturopath adding a dispensary revenue stream without buying inventory upfrontnot Techcyte
  • A clinic that needs patients to actually keep taking a protocol, where auto refills and dose reminders address the adherence problem directlynot Techcyte
  • A multi site integrative health group that wants a single approved catalogue rather than each clinician choosing their own brandsnot Techcyte

Techcyte

  • A clinical laboratory that cannot recruit technologists for high volume manual parasitology screening and needs AI pre screening with human releasenot Fullscript
  • A veterinary reference laboratory processing large volumes of faecal and blood smears that wants Vetcyte to triage the normal casesnot Fullscript
  • A European laboratory that can deploy the CE marked products clinically, which is where Techcyte regulatory position is strongestnot Fullscript
  • An environmental testing laboratory needing consistent microscopy classification across analysts and sitesnot Fullscript

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Fullscript

  • The practitioner sets their own margin on products they clinically recommend, which is a conflict of interest that some professional bodies and patients view badly, and the platform makes the arrangement easy rather than making it visible.
  • The account is free but the practice does not control pricing, catalogue, shipping cost or the patient discount, so the entire economics of the dispensary can be changed by the vendor without the practice having any lever.
  • Converting to a profit account requires personal identity verification, tax details and a bank account, and makes dispensary earnings the practitioner personal taxable income to report, which is administrative work no one warns about at signup.
  • Product availability and shipping are geographically limited, so practices outside the supported countries cannot use it at all and cross border patients will find items unavailable at checkout.
  • Patient refill schedules, plan history and a slice of practice revenue accumulate inside a platform the practice cannot export in a form another dispensary would accept, so switching later means asking every patient to re-enrol somewhere else.

Techcyte

  • Regulatory status runs the opposite way to what most buyers assume: the products are CE marked and clinically deployed in Europe while several United States offerings including Fusion Parasitology are labelled research use only and not for diagnostic use, so an American laboratory must verify each module individually.
  • Slide scanning for parasitology, haematology and cytology needs multi plane imaging that a histology scanner may not produce, so a laboratory that already owns a scanner often has to buy new hardware, which becomes the biggest line in the project.
  • Each discipline is licensed separately, so a laboratory wanting parasitology, urinalysis and haematology assembles three modules and three validation studies rather than buying one platform.
  • AI pre screening does not remove the need for a qualified reviewer to release results, so the staffing saving is in review time per slide, not in headcount, and business cases that assume otherwise do not hold.
  • Techcyte covers a very wide set of disciplines, which means depth varies between them, and the maturity of a newer module is not the maturity of the parasitology or cytology products that made the company its name.

Pricing, plan by plan

Fullscript

Free
  • PractitionerFree
    • Full catalogue and dispensing at no account fee
    • Lab ordering and results
    • Standard EHR integrations
  • PatientFree
    • No account fee
    • Mobile app with dose reminders
    • Auto refills, cancellable at any time
  • Enterprise$undefined/year
    • Quoted for health systems and multi site groups
    • Centrally managed catalogue with quality standards
    • API level EHR integration

Techcyte

On request
  • Techcyte$undefined/year
    • Priced per slide or per annual specimen volume by discipline
    • Each discipline module licensed separately
    • Slide scanning hardware bought separately, not included

Which should you pick?

Choose Fullscript if

  • You need protocol dispensing.
  • You want to start without paying.
  • You work on Web, iOS, Android.
  • You also want profit dispensary.

Choose Techcyte if

  • You need fusion parasitology suite.
  • You also want cervical cytology.

Questions people ask

Is Fullscript or Techcyte better?
Neither clearly leads. Fullscript starts at Free and Techcyte at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Fullscript or Techcyte?
Fullscript has a free tier; the other does not. Paid plans start at Free for Fullscript and On request for Techcyte.
Does Fullscript or Techcyte run on more platforms?
Fullscript runs on Web, iOS, Android. Techcyte runs on Web.
Can I use Fullscript for free?
Yes. Fullscript has a free tier, so you can try it without paying. Techcyte starts at On request.
What is Fullscript best used for?
Fullscript is most often used for a functional medicine practice that wants to stop holding supplement stock, cash and expiry risk in the clinic, a dietitian or naturopath adding a dispensary revenue stream without buying inventory upfront, a clinic that needs patients to actually keep taking a protocol, where auto refills and dose reminders address the adherence problem directly, a multi site integrative health group that wants a single approved catalogue rather than each clinician choosing their own brands. Of those, a functional medicine practice that wants to stop holding supplement stock, cash and expiry risk in the clinic and a dietitian or naturopath adding a dispensary revenue stream without buying inventory upfront are not what Techcyte is typically brought in for.
What can Fullscript do that Techcyte cannot?
Fullscript covers Protocol dispensing, Profit dispensary, Auto refill, Lab ordering. Techcyte covers Fusion Parasitology Suite, Cervical cytology, Haematology, Urinalysis.

Answered from the vendors’ own pages

Fullscript: Is Fullscript really free for practitioners?

Yes, the account has no fee. Fullscript earns on the supplements sold through it, and a practitioner on a profit account also earns a margin on those sales.

Techcyte: Is Techcyte FDA cleared?

Not uniformly. Several United States offerings, including the Fusion Parasitology Suite, are labelled research use only and not for diagnostic use in the United States. Check the regulatory status of each specific module for your country before purchase.

Fullscript: How do practitioners make money on it?

By converting to a profit dispensary and setting a margin. That requires tax information and a bank account, and the earnings are taxable income.

Techcyte: Can we use it clinically in Europe?

Techcyte solutions are CE marked and clinically deployed across Europe, which is where its regulatory position is strongest. Confirm the current certificate for the specific module.

Fullscript: What do patients pay?

No account fee, and a ten per cent discount on orders if the practitioner runs a no profit dispensary rather than taking a margin.

Techcyte: Does it eliminate the need for a technologist?

No. AI pre screens and prioritises, but a qualified reviewer still releases results. The saving is in review time per slide.

Fullscript: Is there an enterprise option?

Yes, quoted for health systems, adding central catalogue control, API EHR integration and cross site reporting.

Techcyte: Do we need a specific scanner?

Techcyte works with several scanner vendors, but disciplines such as parasitology and haematology need multi plane imaging that many histology scanners cannot produce, so confirm hardware compatibility early.

Share

Related pages

Other head to heads